|
Yale Comprehensive Cancer Center Support Grant
|
2P30CA016359-34
|
$2,531,005
|
$227,790
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-34S1
|
$75,000
|
$6,750
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
XLF in double-strand break repair and chemo/radiosensitization
|
1R01CA166264-01A1
|
$308,125
|
$308,125
|
Povirk, Lawrence
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$291,315
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-13
|
$1,336,045
|
$80,163
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-05S2
|
$37,430
|
$3,369
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-05
|
$1,396,397
|
$125,676
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Widespread vs Selective Screening for Hepatitis B Infection Prior to Chemotherapy
|
1R21CA167202-01A1
|
$171,825
|
$171,825
|
Hwang, Jessica
|
UT MD ANDERSON CANCER CTR
|
|
WESTERN ONCOLOGY RESEARCH CONSORTIUM
|
5U10CA045377-27
|
$589,569
|
$218,141
|
Conlin, Alison
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
6R01CA044722-23
|
$191,385
|
$191,385
|
Studzinski, George
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-29
|
$612,504
|
$238,877
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Vindoline and Vinblastine
|
5R01CA115526-08
|
$307,660
|
$307,660
|
BOGER, DALE
|
SCRIPPS RESEARCH INSTITUTE
|
|
VEGF Gene Amplification/Haplotype as Biomarkers for Bevacizumab in Breast Cancer
|
5R01CA155311-03
|
$303,371
|
$151,686
|
Schneider, Bryan
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-23S1
|
$125,000
|
$47,500
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-23
|
$431,709
|
$164,049
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validation of prognostic and pathway signatures in lethal prostate cancer
|
7U01CA157703-03
|
$511,043
|
$255,522
|
HALABI, SUSAN
|
DUKE UNIVERSITY
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
5R01CA135332-03
|
$297,452
|
$297,452
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-05
|
$331,098
|
$331,098
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
5R01CA140375-04
|
$278,654
|
$139,327
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
5P01CA154291-02
|
$3,054,903
|
$305,490
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$375,513
|
$375,513
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$375,513
|
$187,757
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-39
|
$4,133,528
|
$372,018
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S1
|
$37,429
|
$3,369
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S2
|
$122,414
|
$11,017
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using FAP to Selectively Target Epithelial Cancers
|
5R01CA163930-02
|
$334,999
|
$167,500
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
Using EMP2 for Image Guided Drug Delivery for Breast Cancer
|
5R01CA163971-02
|
$300,377
|
$300,377
|
Wadehra, Madhuri
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIA BC 005673
|
$523,027
|
$366,119
|
Keefer, Larry
|
CCR (NCI)
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
1R01CA172921-01A1
|
$357,673
|
$178,837
|
Albelda, Steven
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of Beta-lapachone for Lung Cancer Chemotherapy
|
2R01CA102792-11
|
$335,140
|
$335,140
|
Boothman, David
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Use of 2-deoxy-D-glucose & PI3K/Akt pathway inhibitors in head & neck cancer ther
|
5K01CA134941-05
|
$113,750
|
$113,750
|
Burnett, Andrean
|
UNIVERSITY OF IOWA
|
|
USE AND OUTCOMES OF INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER
|
5R03CA167454-02
|
$73,027
|
$73,027
|
Tsai, Huei-Ting
|
GEORGETOWN UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S1
|
$12,500
|
$500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S2
|
$12,459
|
$498
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-38
|
$5,870,229
|
$234,809
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-29
|
$1,065,000
|
$415,350
|
Bearden, James
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
2U54CA096300-11
|
$1,077,820
|
$172,451
|
Lopez-Berestein, Gabriel
|
UT MD ANDERSON CANCER CTR
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-27
|
$1,397,496
|
$111,800
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Texas SPORE in Lung Cancer
|
3P50CA070907-15S1
|
$560,104
|
$168,031
|
MINNA, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-29
|
$2,114,386
|
$1,945,235
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S1
|
$74,531
|
$8,198
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S2
|
$49,999
|
$5,500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
$638,139
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-06
|
$1,463,426
|
$87,806
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
1P30CA177558-01
|
$1,402,503
|
$168,300
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-01S1
|
$75,000
|
$9,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S1
|
$113,245
|
$4,530
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S2
|
$71,639
|
$2,866
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-14
|
$1,063,659
|
$42,546
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-26
|
$1
|
$1
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
Total relevant funding to Chemotherapy for this search: $466,489,513
|